Equity · Healthcare
NUVL
NASDAQNuvalent (NUVL)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for NUVL to draw a line in its place.
- Market cap
- 9.8B USD
- EPS, diluted, year to Dec 2025
- −5.85 USD
- 52-week range
- 72 USD – 123.96 USD
- Avg volume
- 501.9K
as of Jul 14, 2026
Have Nuvalent (NUVL) insiders bought or sold shares recently?
NUVL has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 15 July 2026.
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 09 Jul 2026 | Pelish Henry E.Chief Scientific Officer | Sell | 2,111 | 261K USD |
| 06 Jul 2026 | Porter James RichardPresident and CEO | Sell | 30,000 | 3.7M USD |
| 01 Jul 2026 | Noci DarleneChief Development Officer | Sell | 23,000 | 2.8M USD |
| 01 Jul 2026 | Balcom AlexandraChief Financial Officer | Sell | 11,430 | 1.4M USD |
| 29 Jun 2026 | Noci DarleneChief Development Officer | Sell | 5,500 | 679K USD |
| 09 Jun 2026 | Noci DarleneChief Development Officer | Sell | 20,000 | 2.5M USD |
| 08 Jun 2026 | Porter James RichardPresident and CEO | Sell | 30,000 | 2.7M USD |
| 01 Jun 2026 | Balcom AlexandraChief Financial Officer | Sell | 11,430 | 1.1M USD |
| 28 May 2026 | Miller Deborah AnnChief Legal Officer | Sell | 5,500 | 593K USD |
| 28 May 2026 | Noci DarleneChief Development Officer | Sell | 5,500 | 593K USD |
| 04 May 2026 | Porter James RichardPresident and CEO | Sell | 30,000 | 3.1M USD |
| 01 May 2026 | Balcom AlexandraChief Financial Officer | Sell | 11,430 | 1.1M USD |
| Sold | 16 open-market sales | 229,894 | $25.04M |
Showing the 12 most recent of 16 open-market trades in this window. The figures above count all of them.
45 other filings: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 15 Jul 2026 | Flynn James EDirector | Other | 17,262,186 | 2.1B USD |
| 15 Jul 2026 | Meyers Michael L.Director | Other | 8,590 | 638K USD |
| 15 Jul 2026 | Balcom AlexandraChief Financial Officer | Other | 99,883 | 5.5M USD |
| 15 Jul 2026 | Balcom AlexandraChief Financial Officer | Award | 14,350 | |
| 15 Jul 2026 | Srivastava SapnaDirector | Other | 8,590 | 638K USD |
| 15 Jul 2026 | Oliger Christy J.Director | Other | 7,415 | 164K USD |
| 15 Jul 2026 | Squarer RonDirector | Other | 6,281 | |
| 15 Jul 2026 | Turner Christopher DurantChief Medical Officer | Other | 86,980 | 3.9M USD |
| 15 Jul 2026 | Turner Christopher DurantChief Medical Officer | Award | 14,350 | |
| 15 Jul 2026 | Noci DarleneChief Development Officer | Other | 72,467 | 2.1M USD |
| 15 Jul 2026 | Noci DarleneChief Development Officer | Award | 14,350 | |
| 15 Jul 2026 | Lane BenjaminSee Remarks | Other | 57,645 | 2.6M USD |
Showing the 12 most recent of 45 compensation filings in this window. The figures above count all of them.
Which funds hold Nuvalent (NUVL)?
12 of the 45 institutional funds we track reported a Nuvalent position for the quarter ended 30 Jun 2026 — a combined 344.3M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Balyasny Asset Management | New position | 1,037,583 | 128.1M USD | |
| Millennium Management | Added | 404,192 | 49.9M USD | +2,138.4% |
| Soros Fund Management | New position | 300,017 | 37.1M USD | |
| Renaissance Technologies | Added | 280,900 | 34.7M USD | +215.6% |
| Two Sigma Investments | Added | 208,978 | 25.8M USD | +104.6% |
| Tudor Investment Corp | Added | 206,068 | 25.4M USD | +4,865.5% |
| Marshall Wace | Added | 152,122 | 18.8M USD | +4,662.7% |
| Man Group | Added | 80,000 | 9.9M USD | +229.8% |
| Point72 Asset Management | New position | 46,306 | 5.7M USD | |
| Citadel Advisors | Trimmed | 43,937 | 5.4M USD | −73.7% |
Showing the 10 largest of 12 reported positions. The figures above count all of them.
What has been filed or recorded for Nuvalent (NUVL)?
The filings we hold for Nuvalent, newest first: 6 quarterly earnings reports, 2 annual reports and 4 reported financial figures, the latest dated 31 Mar 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −1.39 USD | |
| 31 Mar 2026 | Financials | Total assets | 1.3B USD | at period end |
| 31 Mar 2026 | Financials | Total equity | 1.2B USD | at period end |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −5.85 USD | |
| 31 Dec 2025 | Financials | Net income | −425.4M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −5.85 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −1.70 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −1.39 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −1.18 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −3.93 USD | |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS −1.28 USD | |
| 30 Jun 2024 | Quarterly earnings | Q2 2024 reported | EPS −0.88 USD |
Nuvalent (NUVL): frequently asked questions
What is Nuvalent’s market cap?
Nuvalent is worth 9.8B USD by market value as of 14 Jul 2026, which is the share price times the shares on issue from its SEC filings.
Have Nuvalent insiders bought or sold shares recently?
No Nuvalent insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 15 Jul 2026 (SEC Form 4). See Insiders
Which funds own Nuvalent?
12 of the 45 funds we track reported a Nuvalent position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Balyasny Asset Management, Millennium Management and Soros Fund Management. See Funds
When did Nuvalent last report earnings?
Nuvalent last reported earnings on 31 Mar 2026 for Q1 2026, with EPS of −1.39 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SEC EDGARXBRL company facts, latest period ended 31 Mar 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings